- Redwood City, CA-based Avinger (NASDAQ:AVGR) is set for its IPO of 4,615,384 shares of common stock at $12 - 14.
- The commercial stage medical device company develops image-guided, catheter-based systems used by doctors to treat patients with peripheral arterial disease (PAD). Its current products include the Lightbox imaging console and a family of catheters (Wildcat, Kittycat, Ocelot) which allow physicians to penetrate a total blockage in an artery (chronic total occlusion). A key product in development is the Pantheris, an image-guided atherectomy device that allows physicians to remove arterial plaque in PAD patients with precision.
- Financial performance:
- 2014 (9 mo.) ($000): Revenues: 8,140 (-14.9%); Operating Expenses: 21,250 (-36.1%); Net Loss: (23,829) (+23.9%); CF Ops: (15,748) (+52.9%).
- 2013: Revenues: 12,964 (+51.4%); Operating Expenses: 41,731 (+9.1%); Net Loss: (39,901) (-17.8%); CF Ops: (40,655) (-15.4%).
Avinger on deck for IPO
Recommended For You
More Trending News
About AVGR Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
AVGR | - | - |
Avinger, Inc. |